Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Canaan Can Stock Losing Momentum Price At 0.46 Up 3.46 20260410 SPGI SP Global Inc gains 126 percent on Q4 2025 results as solid revenue growth offsets mild EPS miss III Information Services Group Inc shares rise 264 percent after Q4 2025 earnings outperform analyst expectations How Exodus Movement EXOD innovation pipeline shows in financials Exodus Movement Misses Forecast by 1694 Paramount PZG Stock Up 188 Key Resistance at 142 20260520 Leslies Inc LESL Q1 2026 Earnings WiderThanExpected Loss but Stock Rallies Sigma SGML Q1 2026 Earnings Shine Revenue Growth Fuels Beat Arcadia Biosciences RKDA Rallies 2791 as Bulls Target 129 20260520 Blockchaincom Files Confidentially for IPO as Crypto Listings Regain Momentum Ronald Reagan Institute Skepticism of Government Waste Claims Could Reshape Fiscal Debate Lenovo Shares Surge Over 15 on Record Earnings as AI Revenue Nearly Doubles Elon Musks Lawsuit Against OpenAI and Sam Altman Dismissed as Court Rejects 150B Claim AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices Puig Shares Slide as Este Lauder Collaboration Discussions End European Markets Edge Higher CIB Q4 2025 Earnings Massive EPS Miss as Company Reports Deep Loss OXLCO Q4 2025 Earnings EPS Misses Estimates Stock Remains Flat FFWM Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement Leidos Q1 2026 Earnings EPS Beat with 586 Surprise Shares Rise Cavco Industries Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction KRNY Q1 2026 Earnings EPS Misses Estimates Amid Cautious Quarter South Plains Financial SPFI Edges Higher as Shares Test Key Levels Landmark Bancorp Inc LARK Declines 311 Testing Support Near 2572 Diversified Energy Company DEC Gains 179 as Shares Test Key Resistance Zone Aldabra 4 Liquidity Opportunity Vehicle ALOV Holds Steady at 993 as Traders Eye Support and Resistance Corcept Therapeutics CORT Rallies Sharply Pushing Toward Resistance at 69